The study was a double-blind, placebo-controlled independent group design in which subjects were randomly allocated to one of two treatment conditions, Bacopa monniera (300 mg) (n = 18) or placebo (n = 20). Neuropsychological testing was conducted before and 2 h after drug administration. No significant changes were found on any of the tests. The findings suggest that Bacopa monniera, at least for the dose administered, has no acute effects on cognitive functioning in normal healthy subjects.

Bacopa monnieri

Health conditions analyzed in this study

Functions related to this study

Mental health

1 supplement Moderately Positive Bacopa monnieri

---

Body systems related to this study

Nervous System

1 supplement Bacopa monnieri